Showing results (61-70 of 95) with videos related to

Sort By:
Pageof 10
European Journal of Immunology|June 27, 2015
Metabolic plasticity of human T cells: Preserved cytokine production under glucose deprivation or mitochondrial restriction, but 2-deoxy-glucose affects effector functionsKathrin Renner, Anna-Lena Geiselhöringer, Matthias Fante, et al.
Immunology|December 30, 2014
Basophils inhibit proliferation of CD4⁺ T cells in autologous and allogeneic mixed lymphocyte reactions and limit disease activity in a murine model of graft versus host diseaseFabian J Hermann, Manuel Rodriguez Gomez, Kristina Doser, et al.
Vaccine|May 29, 2021
Primary vaccination in adult patients after allogeneic hematopoietic stem cell transplantation - A single center retrospective efficacy analysisClara Sattler, Petra Hoffmann, Philipp Yorck Herzberg, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 1, 2006
Isolation of CD4+CD25+ regulatory T cells for clinical trialsPetra Hoffmann, Tina J Boeld, Ruediger Eder, et al.
Transplantation|May 23, 2002
Mixed chimerism and immunosuppressive drug withdrawal after HLA-mismatched kidney and hematopoietic progenitor transplantationMaria T Millan, Judith A Shizuru, Petra Hoffmann, et al.
International Immunopharmacology|November 9, 2005
A fetal sheep liver extract containing immunostimulatory substances including LPS acts as leukocyte activator in cells of LPS responder and non responder miceSilke Müller, Petra Hoffmann, Ulrich V D Esche, et al.
European Journal of Immunology|August 19, 2007
DNA demethylation in the human FOXP3 locus discriminates regulatory T cells from activated FOXP3(+) conventional T cellsUdo Baron, Stefan Floess, Georg Wieczorek, et al.
Scandinavian Journal of Immunology|January 24, 2022
Physiological levels of 25-hydroxyvitamin D3 induce a suppressive CD4+ T cell phenotype not reflected in the epigenetic landscapeCarina Matos, Kathrin Renner, Alice Peuker, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 12, 2026
Engineered CD40-biosensor-expressing Treg cells as a cell therapy approach for inflammatory diseasesSebastian Bittner, Lisa Schmidleithner, Brigitte Ruhland, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 26, 2022
Biosensors for inflammation as a strategy to engineer regulatory T cells for cell therapySebastian Bittner, Brigitte Ruhland, Veronika Hofmann, et al.
Pageof 10